Clinical Trials Sponsored by Zealandina Agency

Total 1863 results

Zealandina Agency

Completed

Mountain Food and Natural Probiotic in Nutrition

Immune Deficiency

United Kingdom
Assistance Publique - Hôpitaux de Paris
Agence Nationale de Recherche (ANR) National Research Agency

Completed

Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and Adolescents (MENTALPED)

Mental Disorder, Child

France
Valencian Innovation Agency

Not yet recruiting

Evaluation of the Colonization Capacity of a Probiotic Bacterium. (BIOPRED)

Obese | Weight, Body

Spain
Groupe d'Etude sur le Risque d'Exposition des Soignants...
Agence Regionale de Sante d'Ile de France; National Agency of Public Health

Completed

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region (GriCoVax)

Pregnant Women | Influenza Vaccination | Pertussis Vaccine | Healthcare Worker Patient Transmission

France
British Columbia Cancer Agency

Not yet recruiting

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer (PATH)

Head and Neck Cancer
British Columbia Cancer Agency

Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc (PREDiCTc)

Cancer

Canada
British Columbia Cancer Agency

Recruiting

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Prostatic Cancer | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Recruiting

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Canada
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
Environmental Protection Agency (EPA)

Enrolling by invitation

Modification of Ambient Air Pollution Exposure and Cardiopulmonary Outcomes by Socioeconomic Status and Nutrition (SENSE)

Air Pollution | Pollution; Exposure | Nutrition, Healthy

United States
British Columbia Cancer Agency

Withdrawn

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Neuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid Tumor

Canada
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
British Columbia Cancer Agency

No longer available

18F-FDOPA PET in Neuroendocrine Tumours

Thyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | Insulinoma

Canada
British Columbia Cancer Agency

Active, not recruiting

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Metastatic Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults (RECAP)

Exposure to Pollution

United States
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath (Covid-VOC)

Covid19

Canada
British Columbia Cancer Agency

Completed

18F-AmBF3-TATE PET/CT for Imaging NET Patients

Neuroendocrine Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers (Geminoz)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Completed

18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

Melanoma | Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms

Canada
British Columbia Cancer Agency

Unknown

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Arthralgia | Myalgia | Invasive Breast Cancer | Chemotherapeutic Toxicity
Environmental Protection Agency (EPA)

Completed

The Interaction of Social Factors With Air Pollution (SOZIAL)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Unknown

Feasibility Study of MRI Imaging on Parotid Gland Stimulation (SPIT)

Parotid Neoplasms

Canada
British Columbia Cancer Agency

Withdrawn

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effects of Diesel Exhaust and Ozone Exposure (Lamarck)

Exposure to Pollution | Inhalation of Ozone

United States
British Columbia Cancer Agency

Unknown

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Rectal Bleeding

Canada
British Columbia Cancer Agency

Unknown

Randomized Anastrozole Exercise Trial (RAE)

Musculoskeletal Symptoms

Canada
British Columbia Cancer Agency

Completed

Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (Anterior EPI)

Breast Cancer

Canada
Environmental Protection Agency (EPA)

Completed

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Healthy

United States
International Atomic Energy Agency

Completed

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Head and Neck Cancer
British Columbia Cancer Agency

Completed

Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (FOSAVANCE)

Ovarian Cancer

Canada
British Columbia Cancer Agency

Completed

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

Advanced Colorectal Cancer

Canada
British Columbia Cancer Agency

Recruiting

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Prostate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer

Canada
British Columbia Cancer Agency

Recruiting

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Pathologic Processes | Neoplasms | Neoplasm Metastasis | Neoplastic Processes

Canada
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
British Columbia Cancer Agency

Recruiting

Partial Prostate Salvage High Dose Rate Brachytherapy (SalvageHDR)

Recurrent Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer (TAPER)

Endometrial Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
British Columbia Cancer Agency

Completed

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases (Amadeus)

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

US-CT Fusion for Post Implant Dosimetry

Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer

Head and Neck Cancer | Radiotherapy Induced Mucositis

Canada
British Columbia Cancer Agency

Terminated

Intraprostatic MAXimal Simultaneous Boost

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

C-arm Cone-beam CT in Prostate Brachytherapy (C-arm)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer

Canada
International Atomic Energy Agency

Completed

Optimization of Radiotherapy in Treatment of Painful Bone Metastasis (bone mets)

Pain | Bone Metastasis

Egypt, Spain, Serbia, Algeria, Brazil, India, Lithuania, Macedonia, The Former Yugoslav Republic of, Mexico, Tunisia, United Kingdom
British Columbia Cancer Agency

Completed

Feasibility of VMAT and CBCT for Head and Neck Carcinomas

Head and Neck Carcinoma

Canada
British Columbia Cancer Agency

Completed

Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy (IGRT)

Radiation Therapy for Primary Breast Cancer

Canada
International Atomic Energy Agency

Completed

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Cervix Cancer

Peru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom

Clinical Trials Sponsored by Zealandina Agency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations